TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
NCT ID: NCT05538806
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
198 participants
OBSERVATIONAL
2023-08-01
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TTFields In GErmany in Routine Clinical Care
NCT03258021
The STAR Prospective Clinical Series
NCT02217150
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
NCT04717739
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
NCT06955208
NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
NCT03194971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
all patients will receive routine clinical care and TTFields
TTFields
all patients will receive routine clinical care and TTFields
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TTFields
all patients will receive routine clinical care and TTFields
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically confirmed pleural mesothelioma without any option of curative resection
* Planned treatment with NovoTTF-200T System according to IFU and medical guidelines
* Life expectancy more than 3 months at day of enrollment
* Signed informed consent for use and processing of data
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NovoCure Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Bremen-Ost
Bremen, City state Bremen, Germany
Lungenklinik Gauting
Gauting, Bavaria, Germany
University Hospital Regensburg
Regensburg, Bavaria, Germany
Asklepios Klinikum Harburg
Harburg, City state of Hamburg, Germany
University Medicine Göttingen
Göttingen, Lower Saxony, Germany
University Hospital Carl Gustav Carus Dresden
Dresden, Saxony, Germany
Charité Universitätsmedizin Berlin
Berlin, , Germany
Lungenklinik Heckeshorn
Berlin, , Germany
Kliniken der Stadt Koeln
Cologne, , Germany
Florence-Nightingale-Hospital
Düsseldorf, , Germany
Klinikum Essen-Mitte
Essen, , Germany
University Hospital Essen
Essen, , Germany
Niels-Stensen Hospital
Georgsmarienhütte, , Germany
Krankenhaus Martha-Maria Halle-Doelau
Halle, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Lungenklinik Hemer
Hemer, , Germany
Evangelisches Krankenhaus Herne
Herne, , Germany
Krankenhaus Bethanien Moers
Moers, , Germany
GEHO Muenster
Münster, , Germany
Fachkliniken Wangen
Wangen, , Germany
Azienda Ospedaliero-Universitaria di Alessandria "SS. Antonio e Biagio e C. Arrigo"
Alessandria, , Italy
Humanitas Gavazzeni
Bergamo, , Italy
Erasmus MC Cancer Centre
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rudolf A Hatz
Role: primary
Michael Ried
Role: primary
André Bethge
Role: primary
Claas Wesseler
Role: primary
Till Ploenes
Role: primary
Nikolaj Frost
Role: primary
Daniel Misch
Role: primary
Carolin Gross-Ophoff-Müller
Role: primary
Martin Metzenmacher
Role: primary
Wolfgang Schuette
Role: primary
Karsten Schulmann
Role: primary
Kato Kambartel
Role: primary
Philipp Meyn
Role: primary
Federica Grosso
Role: primary
Giovanni Luca Ceresoli
Role: primary
Joachim Aerts
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP-RS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.